hypericin has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Alzheimer's disease (AD) and type 2 diabetes (T2D) are two of the most common diseases in elderly population and they have a high rate of comorbidity." | 1.91 | Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioning. ( Gao, LH; Ma, QH; Wang, J; Yan, F; Yuan, X, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Yuan, X | 1 |
Yan, F | 1 |
Gao, LH | 1 |
Ma, QH | 1 |
Wang, J | 1 |
Liang, C | 1 |
Hao, F | 1 |
Yao, X | 1 |
Qiu, Y | 1 |
Liu, L | 1 |
Wang, S | 1 |
Yu, C | 1 |
Song, Z | 1 |
Bao, Y | 1 |
Yi, J | 1 |
Huang, Y | 1 |
Wu, Y | 1 |
Zheng, L | 1 |
Sun, Y | 1 |
Wang, G | 1 |
Yang, X | 1 |
Yang, S | 1 |
Sun, L | 1 |
Li, Y | 1 |
2 other studies available for hypericin and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioning.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Diabetes Mellitus, Type 2; Drug Repositioning; Human | 2023 |
Hypericin maintians PDX1 expression via the Erk pathway and protects islet β-cells against glucotoxicity and lipotoxicity.
Topics: Animals; Anthracenes; Antioxidants; Apoptosis; Cell Line; Cell Survival; Diabetes Mellitus, Type 2; | 2019 |